HASHIR INTERNATIONAL SPECIALIST CLINICS & RESEARCH INSTITUTE FOR MISOPHONIA, TINNITUS AND HYPERACUSIS LTDActive
Key figures
Like most small UK companies, HASHIR INTERNATIONAL SPECIALIST CLINICS & RESEARCH INSTITUTE FOR MISOPHONIA, TINNITUS AND HYPERACUSIS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 162,744 | 158,972 | 135,513 | 123,923 | 113,346 |
| Total assets | — | — | — | — | — |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 113,002 | 146,400 | 124,692 | 108,828 | 87,378 |
| Average number of employees | 1 | 1 | 5 | 10 | 7 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: HASHIR INTERNATIONAL SPECIALIST CLINICS & RESEARCH INSTITUTE FOR MISOPHONIA, TINNITUS AND HYPERACUSIS LTD
Company
HASHIR INTERNATIONAL SPECIALIST CLINICS & RESEARCH INSTITUTE FOR MISOPHONIA, TINNITUS AND HYPERACUSIS LTD is a private limited company registered with Companies House under company number 08533239. It was incorporated on 17 May 2013. Its status is active. The registered office is in Hassocks (BN6). Its nature of business (SIC 2007) is specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £87,378, down 19.7% on the previous year. Cash at bank and in hand was £113,346. The company had an average of 7 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 1 Apr 2027.